FrancophonIA/ELRC3.0 huggingface dataset:
English: Suliqua with alcohol
Slovenian: Zdravilo Suliqua skupaj z alkoholom
English: Frequency Very common Common
Slovenian: Zelo pogosti
English: Suliqua has not been studied in combination with DPP-4 inhibitors, sulfonylureas, glinides, pioglitazone and SGLT-2 inhibitors.
Slovenian: Zdravilo Suliqua ni raziskano v kombinaciji z zaviralci DPP-4, sulfonilsečninami, glinidi, pioglitazonom in zaviralci SGLT-2.
English: For in use storage conditions, see section 6.3
Slovenian: Za pogoje shranjevanja peresnikov, ki so v uporabi, glejte poglavje 6.3.
English: Read the Package Leaflet and these Instructions for Use first
Slovenian: Najprej preberite navodilo za uporabo in ta navodila
English: Use only clear, colourless solution.
Slovenian: Uporabite le bistro, brezbarvno raztopino.
English: • Changes where the injection is given: If you inject Suliqua too often in the same place, you may develop dents at the site, caused by a loss of fat under the skin (lipoatrophy) or you may develop lumps, caused by a build up of fat under the skin (lipohypertrophy).
Slovenian: • Spremembe na mestu injiciranja: Če si zdravilo Suliqua prepogosto injicirate na isto mesto, se vam lahko tam pojavijo vdolbine, ki so posledica izginotja podkožnega maščevja (lipoatrofija), ali se pojavijo bulice, ki so posledica kopičenja podkožnega maščevja (lipohipertrofija).
English: A large amount of data on pregnant women (more than 1,000 pregnancy outcomes) with insulin glargine indicate no specific adverse effects of insulin glargine on pregnancy and no specific malformative nor feto/neonatal toxicity of insulin glargine.
Slovenian: Številni podatki o insulinu glargin v nosečnosti (več kot 1.000 izidov nosečnosti) ne kažejo specifičnih neželenih učinkov insulina glargin na nosečnost; prav tako ne kažejo, da bi insulin glargin povzročal specifične malformacije ali fetotoksične učinke/toksične učinke na novorojenčka.
English: • If you have any questions about your treatment speak to your healthcare professional.
Slovenian: • Če imate vprašanja o svojem zdravljenju, se posvetujte z zdravnikom.
English: • Do not select a dose or press the injection button without a needle attached.
Slovenian: • Ne izberite odmerka in ne pritisnite gumba za injiciranje, če na peresniku ni nameščena igla.
English: End of study (mean)
Slovenian: Na koncu študije (povprečje)
English: Use of glucagon-like peptide-1 (GLP-1) receptor agonists has been associated with a risk of developing acute pancreatitis.
Slovenian: Uporabo agonistov receptorjev glukagonu podobnega peptida 1 (GLP-1, glucagon-like peptide-1) so povezovali s tveganjem za pojav akutnega pankreatitisa.
English: • Healthcare Professional Guide;
Slovenian: • Vodnik za zdravstvene delavce,
English: It is recommended to optimise glycaemic control via dose adjustment based on fasting plasma glucose (see section 5.1).
Slovenian: Urejenost glikemije je priporočljivo optimizirati s prilagajanjem odmerka glede na glukozo v plazmi na tešče (glejte poglavje 5.1).
English: Do not over-tighten.
Slovenian: Ne privijte je preveč.
English: • Oestrogens and progestogens, such as in the contraceptive pill for birth control or use of oestrogens for bone loss (osteoporosis).
Slovenian: • Estrogene in progestagene, na primer v kontracepcijskih tabletah za uravnavanje rojstev ali estrogene zaradi osteoporoze (izgube kostne mase).
English: Some medicines such as antibiotics, oral contraceptives, statins (medicines like atorvastatin to lower cholesterol), acidresistant tablets or capsules that should not stay too long in your stomach may need to be taken at least one hour before or four hours after your Suliqua injection.
Slovenian: Nekatera zdravila, na primer antibiotike, peroralne kontraceptive, statine (zdravila, kot je atorvastatin, za zniževanje holesterola), proti kislini odporne tablete ali kapsule, ki ne smejo predolgo ostati v želodcu, boste morda morali vzeti vsaj eno uro pred injiciranjem zdravila Suliqua ali štiri ure po injiciranju.
English: A. Check the name and expiry date on the label of your pen.
Slovenian: A. Preverite ime zdravila in datum izteka roka uporabnosti na nalepki peresnika.
English: • Angiotensin converting enzyme (ACE) inhibitors, for heart problems or high blood pressure.
Slovenian: • Zaviralce angiotenzinske konvertaze (ACE), za težave s srcem ali visok krvni tlak.
English: Suliqua should be injected once a day within one hour prior to a meal.
Slovenian: Zdravilo Suliqua je treba injicirati enkrat na dan, največ eno uro pred obrokom.
English: There is no therapeutic experience in patients with severe renal impairment (creatinine clearance less than 30 ml/min) or end-stage renal disease.
Slovenian: Pri bolnikih s hudo okvaro ledvic (očistek kreatinina manj kot 30 ml/min) ali končno odpovedjo ledvic ni terapevtskih izkušenj.
English: If you forget to use Suliqua
Slovenian: Če ste pozabili uporabiti zdravilo Suliqua
English: What you need to know before you use Suliqua Do not use Suliqua:
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Suliqua Ne uporabljajte zdravila Suliqua
English: Suliqua should be used with caution in patients receiving oral medicinal products that require rapid gastrointestinal absorption, require careful clinical monitoring or have a narrow therapeutic ratio.
Slovenian: Zdravilo Suliqua je treba previdno uporabljati pri bolnikih, zdravljenih s peroralnimi zdravili, ki zahtevajo hitro absorpcijo v prebavilih, zahtevajo natančen klinični nadzor ali imajo ozko terapevtsko okno.
English: 30-60 dose steps SoloStar
Slovenian: DRUGI PODATKI 30-60 odmernih korakov SoloStar
English: Increase in heart rate has been reported with GLP1RA use and a transient increase was also observed in some studies with lixisenatide.
Slovenian: Med uporabo agonistov receptorjev GLP-1 so poročali o povečanju srčne frekvence; prehodno povečanje so ugotovili tudi v nekaterih študijah z liksisenatidom.
English: The injection sites should be rotated within the same region (abdomen, deltoid, or thigh) from one injection to the next to reduce the risk of lipodystrophy (see section 4.8).
Slovenian: Mesta injiciranja je treba na posameznem predelu (trebuh, deltoidni predel ali stegno) od injekcije do injekcije krožno menjati, da bi zmanjšali tveganje za lipodistrofijo (glejte poglavje 4.8).
English: The apparent volume of distribution of lixisenatide after subcutaneous administration of insulin glargine/lixisenatide combinations (Vz/F) is approximately 100 L. The apparent volume of distribution of insulin glargine after subcutaneous administration of the insulin glargine/lixisenatide combinations (Vss/F) is approximately 1700 L.
Slovenian: Navidezni volumen porazdelitve liksisenatida po subkutani uporabi kombinacije insulina glargin in liksisenatida (Vz/F) je približno 100 l. Navidezni volumen porazdelitve insulina glargin po subkutani uporabi kombinacije insulina glargin in liksisenatida (Vss/F) je približno 1700 l.
English: The following related adverse reactions from clinical investigations are listed below by system organ class and in order of decreasing frequency (very common: ≥1/10; common: ≥1/100 to <1/10;
Slovenian: Naslednji povezani neželeni učinki, ugotovljeni v kliničnih raziskavah, so navedeni spodaj po organskih sistemih in razvrščeni po padajoči pogostnosti (zelo pogosti: ≥ 1/10, pogosti: ≥ 1/100 do < 1/10, občasni: ≥ 1/1.000 do < 1/100, redki: ≥ 1/10.000 do < 1/1.000, zelo redki: < 1/10.000).
English: Neither status for anti-insulin glargine antibodies nor for anti-lixisenatide antibodies had a clinically relevant impact on safety or efficacy.
Slovenian: Niti protitelesa proti insulinu glargin niti proti liksisenatidu niso klinično pomembno vplivala na varnost in učinkovitost.
English: STEP 5: Inject the dose
Slovenian: KORAK: Injicirajte odmerek
English: Suliqua is indicated in combination with metformin for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control when this has not been provided by metformin alone or metformin combined with another oral glucose lowering medicinal product or with basal insulin (see section 4.4 and 5.1 for available data on the different combinations).
Slovenian: Zdravilo Suliqua je v kombinaciji z metforminom indicirano za zdravljenje odraslih s sladkorno boleznijo tipa 2 za izboljšanje urejenosti glikemije, če to ni bilo doseženo z metforminom samim ali v kombinaciji z drugim peroralnim zdravilom za zniževanje glukoze ali z bazalnim insulinom (glejte poglavji 4.4 in 5.1 za razpoložljive podatke o različnih kombinacijah).
English: Hypoglycaemia was the most frequently reported observed adverse reaction during treatment with Suliqua (see section 4.8).
Slovenian: Hipoglikemija je bila najpogosteje opažen neželeni učinek med zdravljenjem z zdravilom Suliqua (glejte poglavje 4.8).
English: Do not leave the pen in a car on an exceptionally warm or cold day.
Slovenian: Ob zelo vročih ali zelo hladnih dneh peresnika ne puščajte v avtu.
English: Results at 30 weeks -Study Type 2 Diabetes Uncontrolled on Basal Insulin mITT population Suliqua
Slovenian: Rezultati po 30 tednih - Študija sladkorne bolezni tipa 2, neurejene z bazalnim insulinom, populacija mZNZ Zdravilo Suliqua
English: • Protease inhibitors, for HIV.
Slovenian: • Zaviralce proteaz, za HIV.
English: • Take care when handling needles to prevent needle injury and cross-infection.
Slovenian: • Pri ravnanju z iglami bodite previdni, da boste preprečili poškodbe z iglo in navzkrižno okužbo.
English: Always use a new needle.
Slovenian: Vedno uporabite novo iglo.
English: Insulin and its analogs lower blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production.
Slovenian: Insulin in njegovi analogi zmanjšajo koncentracijo glukoze v krvi, ker spodbujajo periferni privzem glukoze, zlasti v skeletnem mišičju in maščevju, in zavirajo nastajanje glukoze v jetrih.
English: Gastro-resistant formulations containing substances sensitive to stomach degradation, should be administered 1 hour before or 4 hours after lixisenatide injection.
Slovenian: Gastrorezistentne oblike zdravil, ki vsebujejo snovi, občutljive na razgradnjo v želodcu, je treba uporabiti 1 uro pred injiciranjem liksisenatida ali 4 ure po injiciranju.
English: How to store your pen Before first use
Slovenian: Shranjevanje peresnika Pred prvo uporabo
English: • Do not put the inner needle cap back on.
Slovenian: • Notranjega pokrovčka igle ne nameščajte nazaj.
English: Close glucose monitoring is recommended during the transfer and in the following weeks.
Slovenian: Med prehodom in v naslednjih tednih je priporočljiv natančen nadzor glukoze.
English: A postprandial injection of Lixisenatide also slows gastric emptying thereby reducing the rate at which meal-derived glucose is absorbed and appears in the circulation.
Slovenian: Postprandialno injiciranje liksisenatida upočasni tudi praznjenje želodca in tako zmanjša hitrost, s katero se glukoza iz obroka absorbira in se pojavi v krvnem obtoku.
English: • severe pain in your stomach area (abdomen) that will not go away.
Slovenian: • če imate hude bolečine v trebuhu, ki ne minejo.
English: Having too low or too high blood sugar (see information in the box at the end of this leaflet)can affect your ability to drive and use tools or machines.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Prenizek ali previsok krvni sladkor (glejte informacije v okviru na koncu tega navodila za uporabo) lahko vplivata na sposobnost vožnje, uporabe orodij in upravljanja s stroji.
English: The randomised type 2 diabetes population had the following characteristics: Mean age was 58.4 years with the majority (57.1%) being aged of 50 to 64 years, and 50.6 percent were male.
Slovenian: Randomizirana populacija s sladkorno boleznijo tipa 2 je imela naslednje značilnosti: povprečna starost je bila 58,4 leta; večina (57,1 %) bolnikov je bila stara od 50 do 64 let.
English: Reasons why hypoglycaemia may happen:
Slovenian: Razlogi, zaradi katerih se lahko pojavi hipoglikemija:
English: In clinical studies with insulin glargine (100 units/ml) the glucose-lowering effect on a molar basis (i.e., when given at the same doses) of intravenous insulin glargine is approximately the same as that for human insulin.
Slovenian: V kliničnih študijah z insulinom glargin (100 enot/ml) je bil učinek intravensko uporabljenega insulina glargin na znižanje glukoze na molarni osnovi (tj. uporabljenega v enakih odmerkih) približno tolikšen kot učinek humanega insulina.
English: 10-40 dose steps SoloStar
Slovenian: DRUGI PODATKI 10-40 odmernih korakov SoloStar
English: At all time points, 30-week mean plasma glucose values were lower in the Suliqua group than in both the insulin glargine group and the lixisenatide group, with the only exception of the pre-breakfast value which was similar between the Suliqua group and the insulin glargine group.
Slovenian: 30-tedenske povprečne vrednosti glukoze v plazmi so bile na vseh časovnih točkah nižje v skupini z zdravilom Suliqua kot v skupinah z insulinom glargin in liksisenatidom; edina izjema je vrednost pred zajtrkom, ki je bila v skupini z zdravilom Suliqua podobna kot v skupini z insulinom glargin.
English: • Your healthcare professional will explain the design and features of your Suliqua pen, including how the dose counter of the pre-filled pen device shows the number of dose steps to be injected.
Slovenian: • Vaš zdravnik vam bo razložil zasnovo in lastnosti peresnika Suliqua, vključno s tem, kako števec odmerkov na tem napolnjenem injekcijskem peresniku prikazuje število odmernih korakov, ki bodo injicirani.
English: • Do not put your pen back in the refrigerator.
Slovenian: • Peresnika ne dajte nazaj v hladilnik.
English: Check that the medicine is clear.
Slovenian: Preverite, da je zdravilo bistro.
English: • throw the pen away and use a new one.
Slovenian: • zavrzite ta injekcijski peresnik in uporabite novega.
English: Suliqua is available in two pens, providing different dosing options, i.e. Suliqua (10-40) pen, Suliqua (30-60) pen respectively.
Slovenian: Zdravilo Suliqua je na voljo v dveh peresnikih, ki omogočata različno odmerjanje, tj. v peresniku Suliqua (10-40) in peresniku Suliqua (30-60).
English: • If the patient starts with the Suliqua (10-40) pen, the dose may be titrated up to 40 dose steps with this pen.
Slovenian: • Če bolnik začne zdravljenje s peresnikom Suliqua (10-40), je mogoče odmerek s tem peresnikom prilagoditi do odmerka 40 odmernih korakov.
English: Do not inject Suliqua.
Slovenian: Ne injicirajte si zdravila Suliqua.
English: Of the 1479 patients who started the run-in phase, 1170 were randomised.
Slovenian: Randomiziranih je bilo 1170 od 1479 bolnikov, ki so vstopili v obdobje uvajanja.
English: The impact of the combination of insulin glargine and lixisenatide on the pharmacodynamics of lixisenatide has not been studied in phase 1 studies.
Slovenian: Vpliva kombinacije insulina glargin in liksisenatida na farmakodinamiko liksisenatida v študijah 1. faze niso raziskali.
English: Handling needles • Take care when handling needles to prevent needle injury and cross-infection.
Slovenian: Ravnanje z iglami • Pri ravnanju z iglami bodite previdni, da boste preprečili poškodbe z iglo in navzkrižno okužbo.
English: MACE was defined as the composite of CV death, nonfatal myocardial infarction and nonfatal stroke.
Slovenian: Dogodek MACE je bil opredeljen kot sestavljeni dogodek SŽ smrti, miokardnega infarkta brez smrtnega izida in možganske kapi brez smrtnega izida.
English: Reasons why hyperglycaemia may happen:
Slovenian: Razlogi, zaradi katerih se lahko pojavi hiperglikemija:
English: • You have severe kidney or liver disease, or some other disease such as hypothyroidism.
Slovenian: • če imate hudo bolezen ledvic ali jeter ali kakšno drugo bolezen, npr. nezadostno delovanje ščitnice (hipotiroidizem).
English: • If the patient starts with the Suliqua (30-60) pen, the dose may be titrated up to 60 dose steps with this pen.
Slovenian: • Če bolnik začne zdravljenje s peresnikom Suliqua (30-60), je mogoče odmerek s tem peresnikom prilagoditi do odmerka 60 odmernih korakov.
English: Patients treated with Suliqua should be advised of the potential risk of dehydration in relation to gastrointestinal adverse reactions and take precautions to avoid fluid depletion.
Slovenian: Bolnike, ki prejemajo zdravilo Suliqua, je treba seznaniti z možnim tveganjem za dehidracijo, povezano z neželenimi učinki na prebavilih, in s previdnostnimi ukrepi za preprečitev pomanjkanja tekočine.
English: These changes are not clinically relevant and, therefore, no dose adjustment for atorvastatin is required when co-administered with lixisenatide.
Slovenian: Te spremembe klinično niso pomembne, zato odmerka atorvastatina med sočasno uporabo z liksisenatidom ni treba prilagoditi.
English: C. Check that the medicine is clear.
Slovenian: C. Preverite, da je zdravilo bistro.
English: • If you still find it hard to press in, get a new pen.
Slovenian: • Če gumb še vedno težko pritisnete, vzemite nov peresnik.
English: Oral anti-diabetic treatment (insulin naïve patients)
Slovenian: Zdravljenje s peroralnimi antidiabetiki (bolniki, ki še niso prejemali insulina)
English: After subcutaneous administration of insulin glargine/lixisenatide combinations to patients with type 1 diabetes, the median tmax of lixisenatide was in the range of 2.5 to 3.0 hours.
Slovenian: Po subkutani uporabi kombinacije insulin glargin/liksisenatid pri bolnikih s sladkorno boleznijo tipa 1 je bil mediani tmax liksisenatida od 2,5 do 3,0 ure.
English: In the Add-on to metformin clinical study the treatment was started at 10 dose steps (10 units insulin glargine and 5 mcg lixisenatide).
Slovenian: V klinični študiji dodatka k metforminom so zdravljenje začeli z 10 odmernimi koraki (10 enot insulina glargin in 5 mcg liksisenatida).
English: Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic medicinal products (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors.
Slovenian: Med snovmi, ki lahko zmanjšajo znižanje glukoze v krvi, so kortikosteroidi, danazol, diazoksid, diuretiki, glukagon, izoniazid, estrogeni in progestageni, derivati fenotiazina, somatropin, simpatikomimetična zdravila (npr. adrenalin, salbutamol, terbutalin), ščitnični hormoni, atipična antipsihotična zdravila (npr. klozapin in olanzapin) in zaviralci proteaz.
English: Check the name and expiry date on the label of your pen.
Slovenian: Preverite ime zdravila in datum izteka roka uporabnosti na nalepki peresnika.
English: Lixisenatide stimulates insulin secretion when blood glucose is increased but not at normoglycaemia, which limits the risk of hypoglycaemia.
Slovenian: Liksisenatid spodbudi izločanje insulina, če je glukoza v krvi zvišana, ne pa tudi med normoglikemijo; to zmanjša tveganje za hipoglikemijo.
English: Neonatal growth was reduced in male rats exposed to high doses of lixisenatide during late gestation and lactation, with a slightly increased pup mortality observed.
Slovenian: Rast novoskotenih mladičev je bila upočasnjena pri podganjih samcih, ki so bili med poznim obdobjem gestacije in med obdobjem dojenja izpostavljeni velikim odmerkom liksisenatida; opažali so rahlo večjo umrljivost mladičev.
English: There have been few reported events of acute pancreatitis with lixisenatide although a causal relationship has not been established.
Slovenian: Z liksisenatidom so bili opisani maloštevilni primeri akutnega pankreatitisa, toda vzročne povezanosti niso ugotovili.
English: Insulin glargine daily dose Baseline (mean) Endpoint (mean) LS insulin dose change at week 30 (mean) *Not included in the pre-specified step-down testing procedure **2 hour PPG minus the pre-meal glucose value
Slovenian: Dnevni odmerek insulina glargin Izhodiščno (povprečje) Končna točka (povprečje) Odmerek insulina po metodi NK po 30 tednih (povprečje) *Ni vključeno v vnaprej opredeljeni postopek redukcijskega testiranja ("step-down") **Vrednost glukoze 2 uri po obroku minus vrednost glukoze pred obrokom
English: • Corticosteroids such as cortisone and prednisolone, for inflammation.
Slovenian: • Kortikosteroide, na primer kortizon ali prednizolon, za vnetje.
English: Insulin glargine (100 units/ml)** ≥20 to <30 units
Slovenian: Insulin glargin (100 enot/ml)** ≥20 do <30 enot
English: Suliqua must not be drawn from the cartridge of the pre-filled pen into a syringe to avoid dosing errors and potential overdose (see section 4.4).
Slovenian: Zdravila Suliqua se iz vložka napolnjenega injekcijskega peresnika ne sme izvleči v injekcijsko brizgo, da ne bi prišlo do napak pri odmerjanju in morebitnega prevelikega odmerjanja (glejte poglavje 4.4).
English: Effect of age, race, and gender on the pharmacokinetics of insulin glargine has not been evaluated.
Slovenian: Vpliva starosti, rase in spola na farmakokinetiko insulina glargin niso ocenili.
English: Suliqua should not be used during pregnancy.
Slovenian: Zdravila Suliqua se ne sme uporabljati med nosečnostjo.
English: This will reduce the risk of developing dents or lumps at the site (for more information, see “Other side effects” in section 4).
Slovenian: Tako boste zmanjšali tveganje za pojav vdolbin ali bulic na mestu injiciranja (za več informacij glejte "Drugi neželeni učinki"
English: Your dose of Suliqua is administered as ‘dose steps'.
Slovenian: Odmerek zdravila Suliqua si daste v "odmernih korakih".
English: Thirst, increased need to urinate, tiredness, dry skin, reddening of the face, loss of appetite, low blood pressure, fast heartbeat, and urine test showing glucose and ketone bodies.
Slovenian: Žeja, pogostejše siljenje na vodo, utrujenost, suha koža, pordelost obraza, izguba teka, nizek krvni tlak, hitro bitje srca in test urina, ki pokaže prisotnost glukoze in ketonov.
English: • Diarrhoea Uncommon: may affect up to 1 in 100 people
Slovenian: • driska Občasni: pojavijo se lahko pri največ 1 od 100 bolnikov
English: It is unknown whether insulin glargine or lixisenatide is excreted in human milk.
Slovenian: Ni znano, ali se insulin glargin ali liksisenatid izločata v materino mleko.
English: The AUC and Cmax of the active metabolite (ramiprilat) were not affected.
Slovenian: AUC in Cmax glavnega presnovka (ramiprilata) se nista spremenili.
English: The main reasons for not entering the randomized phase were FPG value >13.9 mmol/L and HbA1c value <7% or >10% at the end of the run-in phase
Slovenian: Glavni razlog, da bolniki niso bili randomizirani, je bila glukoza v plazmi na tešče > 13,9 mmol/l oz. HbA1c < 7 % ali > 10 % na koncu obdobja uvajanja.
English: 10 dose steps (10 units/5 mcg)*
Slovenian: 10 odmernih korakov (10 enot/5 mcg)*
English: The pharmacokinetic and pharmacodynamic findings indicate that the effect of the subcutaneous injection with insulin glargine is principally based on exposure to M1.
Slovenian: Glavna spojina v plazmi je presnovek M1. Farmakokinetični in farmakodinamični izsledki kažejo, da učinek subkutano injiciranega insulina glargin temelji predvsem na izpostavljenosti presnovku M1.
English: The label must always be checked before each injection to avoid medication errors between Suliqua and other injectable anti-diabetic medicinal products, including the 2 different pens of Suliqua (see section 4.4).
Slovenian: Pred injiciranjem je vedno treba preveriti nalepko, da bi preprečili napake pri uporabi zdravila zaradi zamenjave med zdravilom Suliqua in drugimi zdravili za sladkorno bolezen, namenjenimi za injiciranje, vključno z 2 različnima peresnikoma zdravila Suliqua (glejte poglavje 4.4).
English: • You are recovering from an illness or from fever.
Slovenian: • Okrevate po bolezni ali zvišani telesni temperaturi.
English: • if there are particles in the Suliqua.
Slovenian: • Če so v zdravilu Suliqua delci.